Knoll Capital Management, LLC Avadel Pharmaceuticals PLC Transaction History
Knoll Capital Management, LLC
- $148 Million
- Q2 2024
A detailed history of Knoll Capital Management, LLC transactions in Avadel Pharmaceuticals PLC stock. As of the latest transaction made, Knoll Capital Management, LLC holds 600,000 shares of AVDL stock, worth $9.18 Million. This represents 5.7% of its overall portfolio holdings.
Number of Shares
600,000
Previous 600,000
-0.0%
Holding current value
$9.18 Million
Previous $10.1 Million
16.76%
% of portfolio
5.7%
Previous 6.33%
Shares
3 transactions
Others Institutions Holding AVDL
# of Institutions
12Shares Held
7.03MCall Options Held
0Put Options Held
0-
Vivo Capital, LLC Palo Alto, CA3.97MShares$60.8 Million8.25% of portfolio
-
Tri Locum Partners LP New York, NY1.19MShares$18.2 Million4.32% of portfolio
-
Bio Impact Capital LLC Cambridge, MA783KShares$12 Million1.77% of portfolio
-
Knott David M Jr Syosset, NY333KShares$5.09 Million1.87% of portfolio
-
Schulhoff & CO Inc137KShares$2.1 Million0.81% of portfolio
About AVADEL PHARMACEUTICALS PLC
- Ticker AVDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 60,581,300
- Market Cap $927M
- Description
- Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...